Search

everythinglearnresearchcommunity

for

Search:↓

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Korean psoriasis patients still use alternative medicine despite effective biologics.

Counterfeit drugs for bodybuilders often contain incorrect or contaminated ingredients and look like real products.

Many black market drugs for bodybuilders are fake and mislabeled.

Current methods for assessing bioequivalence of topical drugs are limited and lack standardization.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

Advocacy groups should avoid marketing partnerships that may imply drug endorsements.

Engineered cytokines show promise for improving tissue healing and safety in regenerative medicine.

Different crystal forms of drugs can change their effectiveness.

3D bioprinting holds promise for medicine but needs more research and clear regulations.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

The document concludes that developing generic topical drugs requires ensuring they match the original in quality, composition, and structure, and often involves complex testing and regulatory steps.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Photobiomodulation therapy shows promise in treating various health conditions by using specific light wavelengths.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Biologics for severe asthma have known side effects, but some new risks need more study.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

The FDA should use negotiated rulemaking to improve generic drug safety regulations.

New drug delivery systems improve treatment effectiveness and patient experience.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Biopolymers are increasingly used in cosmetics for their non-toxicity and skin benefits, with future biotech advancements likely to expand their applications.

EV-based drug delivery shows promise but faces challenges in standardization and scalability.

Innovative methods are reducing animal testing and improving biomedical research.

Dosage regime inventions can be patentable in China, but legal uncertainty exists.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.